FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry and medicine, namely to immunology, and is a composition having immunostimulating effect for sublingual use consisting of a double-stranded RNA bacteriophage F6 in amount of 0.5 ± 0.1 mg, a single-chain yeast RNA of 4.5 ± 0.5 mg, pectin in amount of 21 ± 3 mg, calcium lactate in amount of 15 ± 3 mg, dextran in the amount of 100 ± 10 mg, sodium chloride in amount of 9 ± 1 mg and water purified to 1 ml.
EFFECT: invention provides immunostimulating action, as well as the possibility of obtaining a stable composition.
1 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
ANTIVIRAL AGENT | 1996 |
|
RU2123339C1 |
PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
METHOD OF TREATING AVIAN INFLUENZA | 2012 |
|
RU2502512C2 |
RIDOSTIN AS INTERFERON INDUCTOR | 1993 |
|
RU2083221C1 |
METHOD FOR PREVENTION OF GASTROINTESTINAL DISEASES OF YOUNG CATTLE | 2019 |
|
RU2722161C1 |
SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
METHOD FOR CELLULAR LABORATORY IMMUNITY OF LABORATORY ANIMALS | 2018 |
|
RU2709809C1 |
METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
ANTIVIRAL AGENT FOR PREVENTION OF INFECTIOUS BOVINE RHINOTRACHEITIS | 2014 |
|
RU2571935C1 |
Authors
Dates
2018-03-15—Published
2017-05-31—Filed